Nobody wants CBD labeling that looks like medicine (ie CV packaging looks generic label aspirin). They want a hemp product. I know of maybe 3 companies who have it right not that it matters at the moment— sector is terrible.
Cant argue with you much. Agree on cw. If they report same or better revenues than cvsi management needs to go. Lot of defenders of management here though. Will they still be if cw meets expectations? My guess is probably.
News 
Market Data 
Discover 
